Impact of Oxygen Therapy on Fatigue in Patients With Hypermobile-type Ehlers-Danlos Syndrome
Status:
Not yet recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The hypothesis of the OXYSED study is that the delivery of 3 months of oxygen therapy via an
oxygen concentrator would reduce fatigue, pain, headaches, kinesiophobia, drug intake,
dyspnea, and improve walking performance, quality of sleep and quality of life of patients
with Ehlers Danlos syndrome hypermobility type (EDS / HT).